Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2768 Amiloride1 CitationSummary: Amiloride (MK-870) is an inhibitor of epithelial sodium channels and urokinase-type fibrinogen activator receptors. -
BA2769 MS1943Summary: MS1943 is a first-of-its-kind, orally bioactive, selective degradant. -
BA2770 MivebresibSummary: Mivebresib (ABBV-075) is an effective. -
BA2771 DCZ0415Summary: DCZ0415 is a potent inhibitor that impairs non-homologous end-joining repair and inhibits activity. -
BA2772 FluorizolineSummary: Fluorizoline selectively binds directly to prohibitin 1 and 2 and induces apoptosis. -
BA2773 GSK778Summary: GSK778 (iBET-BD1) is a potent and selective inhibitor of the bromodomain of the protein. -
BA2774 PFK-158Summary: PFK-158 is a potent, selective inhibitor. -
BA2775 α-NETASummary: Alpha-NETA is a potent, noncompetitive inhibitor of choline acetyltransferase. -
BA2776 GSK2256098Summary: GSK2256098 is a selective kinase inhibitor. -
BA2777 NU9056Summary: NU9056 is a potent and selective histone acetyltransferase inhibitor.

